End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,845 KRW | +0.71% | -3.71% | -50.93% |
Jun. 10 | Shaperon and Dong-A St Sign MOU for Nanobody-Based New Drug Development | CI |
Mar. 18 | Shaperon Enrolls its First Patient in Phase 2 U.S. Clinical Trial for Atopic Dermatitis Therapy 'Nugel' | CI |
Business Summary
Sales per Business
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Medicines
100.0
%
| 2,000 | 100.0 % | 215 | 100.0 % | -89.24% |
Sales per region
KRW in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
South Korea
100.0
%
| 2,000 | 100.0 % | 215 | 100.0 % | -89.24% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Seung-Yong Sung
CEO | Chief Executive Officer | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 23,071,031 | 17,153,170 ( 74.35 %) | 0 | 74.35 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
-50.93% | 30.64M | |
+15.01% | 122B | |
+19.35% | 113B | |
+6.55% | 22.84B | |
-19.42% | 20.72B | |
-16.19% | 16.51B | |
-12.67% | 16.39B | |
-43.53% | 15.83B | |
+2.38% | 13.49B | |
+74.86% | 11.67B |
- Stock Market
- Equities
- A378800 Stock
- Company Shaperon Inc.